Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Italian region weighs up thalassaemia R&D (research and development) options:

This article was originally published in Clinica

Executive Summary

Italy's Marche region has declined an offer by the central government to transform the San Salvatore hospital, Pesaro, into a national centre for research into thalassaemia. During a meeting last week with the ministers of health and of the economy, the regional authorities said they were considering giving foundation status to only part of the hospital, namely the haematology department. The health ministry has expressed regret at the decision, since the centre will miss the opportunity of becoming part of the national and European networks of centres of research excellence. Neither will the centre be entitled to the substantial funding the government has set aside in 2002 for this programme. The Marche region has yet to formally announce its decision to the central government.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT067768

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel